VRP 700

Drug Profile

VRP 700

Alternative Names: VRP-700

Latest Information Update: 28 Sep 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Unknown
  • Developer Verona Pharma
  • Class Antitussives
  • Mechanism of Action Sensory receptor cell inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes
  • Available For Licensing Yes - Cough

Highest Development Phases

  • No development reported Cough

Most Recent Events

  • 28 Sep 2016 VRP 700 is available for licensing as of 28 Sep 2016. http://www.veronapharma.com/joomla/index.php/products
  • 18 Feb 2016 No development reported - Phase-II for Cough in United Kingdom (Inhalation)
  • 25 Mar 2013 Phase-II clinical trials in Cough in United Kingdom (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top